Φορτώνει......
DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities
Advances in DNA sequencing technology have created a wealth of information regarding the genomic landscape of prostate cancer. It had been thought that BRCA1 and BRCA2 mutations were associated with only a small fraction of prostate cancer cases. However, recent genomic analysis has revealed that ge...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Oncologist |
---|---|
Κύριοι συγγραφείς: | , , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
AlphaMed Press
2016
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4978560/ https://ncbi.nlm.nih.gov/pubmed/27317574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0135 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|